Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

NuVasive, Inc. NUVA NASDAQ

NASDAQ Global Select • Healthcare • Medical - Devices • US • USD

SharesGrow Score
48/100
1/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$58.00
+45.9%

NuVasive, Inc. (NUVA) is a Medical - Devices company in the Healthcare sector, currently trading at $39.75. It has a SharesGrow Score of 48/100, indicating a mixed investment profile with 1 out of 7 criteria passed.

Analyst consensus target is NUVA = $58 (+45.9% upside).

Financials: revenue is $1.2B, +1.3%/yr average growth. Net income is $40M, growing at -22.1%/yr. Net profit margin is 3.4% (thin). Gross margin is 72% (-1.3 pp trend).

Balance sheet: total debt is $1.0B against $869M equity (Debt-to-Equity (D/E) ratio 1.16, moderate). Current ratio is 1.21 (adequate). Debt-to-assets is 45.2%. Total assets: $2.2B.

Analyst outlook: 13 / 35 analysts rate NUVA as buy (37%) — mixed sentiment.

SharesGrow 7-Criteria breakdown: Value 57/100 (Partial), Growth 30/100 (Fail), Past 50/100 (Partial), Health 50/100 (Partial), Moat 70/100 (Pass), Future 52/100 (Partial), Income 30/100 (Fail).

$58.00
▲ 45.91% Upside
Average Price Target
Based on 35 Wall Street analysts offering 12-month price targets for NuVasive, Inc., the average price target is $58.00, with a high forecast of $64.00, and a low forecast of $50.00.
Highest Price Target
$64.00
Average Price Target
$58.00
Lowest Price Target
$50.00

NUVA SharesGrow Score Overview

48/100
SharesGrow Score
Mixed signals — some strengths
View full scorecard →
VALUE 57/100
Valuation — P/E, PEG, Forward PEG
GROWTH 30/100
Financials — average growth
PAST 50/100
strong — trend
HEALTH 50/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 70/100
Gross margin is + market cap
FUTURE 52/100
Analyst outlook — as buy
INCOME 30/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — NUVA

~
VALUE Partial
57/100
NUVA trades at a trailing Price-to-Earnings (P/E) of N/A (S&P 500 average ~25). Analyst consensus target is $58, implying +45.9% from the current price $40. Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + upside (25%) + trailing PEG (20%). ≥ 60 = Pass.
View details →
✗
GROWTH Fail
30/100
NUVA: +1.3%/yr revenue is, -22.1%/yr Net income is average growth. mixed. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
~
PAST Partial
50/100
NUVA: 2 / 4 years profitable. weak. Score = 2 / 4 × 100. ≥ 80 = Pass.
View details →
~
HEALTH Partial
50/100
Balance sheet NUVA: Debt-to-Equity (D/E) ratio 1.16 (moderate), Current ratio is 1.21 (adequate). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
✓
MOAT Pass
70/100
NUVA: Gross margin is 72% (-1.3 pp trend), $2B market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 70/100. ≥ 70 = Pass.
View details →
~
FUTURE Partial
52/100
Analyst outlook: 13 / 35 analysts rate NUVA as buy (37%). Analyst consensus target is $58 (+45.9% upside). Score: 60% buy consensus + 40% upside. ≥ 60 = Pass.
View details →
✗
INCOME Fail
30/100
NUVA: Net profit margin is 3.4%. thin (0-5%). Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.
View details →

Stock Chart & Stats

Market Data
52-Week Range35.17-49.53
Volume30.59M
Avg Volume (30D)1.41M
Market Cap$2.08B
Beta (1Y)1.07
Share Statistics
EPS (TTM)0.78
Shares Outstanding$57.36M
IPO Date2004-05-13
Employees3,000
CEOJ. Christopher Barry
Financial Highlights & Ratios
Revenue (TTM)$1.2B
Gross Profit$865.44M
EBITDA$211.8M
Net Income$40.41M
Operating Income$64.77M
Total Cash$248.66M
Total Debt$1.01B
Net Debt$757.42M
Total Assets$2.22B
Price / Earnings (P/E)51
Price / Sales (P/S)1.73
Analyst Forecast
1Y Price Target$60.00
Target High$64.00
Target Low$50.00
Upside+50.9%
Rating ConsensusHold
Analysts Covering35
Buy 37% Hold 60% Sell 3%
Company Info
CountryUS
ExchangeNASDAQ Global Select
CurrencyUSD
ISINUS6707041058

Price Chart

Track all markets on TradingView
NUVA
NuVasive, Inc. ↗  ·  NASDAQ Global Select
Healthcare • Medical - Devices
35.17 52WK RANGE 49.53

People Also View

MASI
MASI
Masimo Corporation
$178.39
-0.04%
 GKOS
GKOS
Glaukos Corporation
$120.52
+0.86%
 BRKR
BRKR
Bruker Corporation
$39.90
+2.18%
 LIVN
LIVN
LivaNova PLC
$64.99
+0.63%
 ITGR
ITGR
Integer Holdings Corporation
$88.63
+1.03%
 HSKA
HSKA
Heska Corporation
$119.99
+0.00%
 CNMD
CNMD
CONMED Corporation
$39.73
+3.30%
 AVNS
AVNS
Avanos Medical, Inc.
$24.63
+69.51%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message